Avelumab (anti-PD-L1)

Product Name： Avelumab  biosimilar

CAS No.:    1537032-82-8                                                 

Molecular Weight： 147 kDa                   

Type:    Whole antibody                     

Target：  PD-L1
Antibody Form:  Purified immunoglobulin
Physical Form:  Solution
Storage:  -70±15℃ for long-term storage, 2-8℃ for short-term storage, away from light.

Description 

Avelumab biosimilar is a programmed death ligand-1 (PD-L1) blocking antibody. Avelumab is a human IgG1 lambda monoclonal antibody that has a molecular weight of approximately 147 kDa. 

Biological Activity
Avelumab (anti-PD-L1) (MSB0010718C) is a fully human IgG1 monoclonal antibody that targets the protein programmed death-ligand 1 (PD-L1). Avelumab exhibits potential antibody-dependent cell-mediated cytotoxicity and is used for the treatment of several kinds of carcinoma.

For research use only. Not for use in humans